Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 3
1989 2
1990 4
1991 5
1992 2
1993 2
1994 6
1995 8
1996 10
1997 7
1998 1
1999 5
2000 5
2001 3
2002 9
2003 5
2004 8
2005 6
2006 13
2007 9
2008 5
2009 10
2010 10
2011 8
2012 10
2013 7
2014 9
2015 9
2016 4
2017 5
2018 9
2019 7
2020 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Results by year

Filters applied: . Clear all
Page 1
Pathological features of vessel co-option versus sprouting angiogenesis.
Latacz E, Caspani E, Barnhill R, Lugassy C, Verhoef C, Grünhagen D, Van Laere S, Fernández Moro C, Gerling M, Dirix M, Dirix LY, Vermeulen PB. Latacz E, et al. Among authors: dirix ly. Angiogenesis. 2020 Feb;23(1):43-54. doi: 10.1007/s10456-019-09690-0. Epub 2019 Oct 26. Angiogenesis. 2020. PMID: 31655928 Review.
Trastuzumab emtansine in breast cancer.
Dirix LY, Rutten A, Huget P, Dirix M. Dirix LY, et al. Expert Opin Biol Ther. 2013 Apr;13(4):607-14. doi: 10.1517/14712598.2013.778238. Expert Opin Biol Ther. 2013. PMID: 23477731 Review.
Soft tissue sarcoma in adults.
Dirix LY, Vermeulen P, De Wever I, Van Oosterom AT. Dirix LY, et al. Curr Opin Oncol. 1997 Jul;9(4):348-59. doi: 10.1097/00001622-199709040-00008. Curr Opin Oncol. 1997. PMID: 9251885 Review.
Pathway-based subnetworks enable cross-disease biomarker discovery.
Haider S, Yao CQ, Sabine VS, Grzadkowski M, Stimper V, Starmans MHW, Wang J, Nguyen F, Moon NC, Lin X, Drake C, Crozier CA, Brookes CL, van de Velde CJH, Hasenburg A, Kieback DG, Markopoulos CJ, Dirix LY, Seynaeve C, Rea DW, Kasprzyk A, Lambin P, Lio' P, Bartlett JMS, Boutros PC. Haider S, et al. Among authors: dirix ly. Nat Commun. 2018 Nov 12;9(1):4746. doi: 10.1038/s41467-018-07021-3. Nat Commun. 2018. PMID: 30420699 Free PMC article.
The interaction between ER and NFκB in resistance to endocrine therapy.
Sas L, Lardon F, Vermeulen PB, Hauspy J, Van Dam P, Pauwels P, Dirix LY, Van Laere SJ. Sas L, et al. Among authors: dirix ly. Breast Cancer Res. 2012 Aug 31;14(4):212. doi: 10.1186/bcr3196. Breast Cancer Res. 2012. PMID: 22963717 Free PMC article. Review.
The rationale for mTOR inhibition in epithelial ovarian cancer.
Trinh XB, van Dam PA, Dirix LY, Vermeulen PB, Tjalma WA. Trinh XB, et al. Among authors: dirix ly. Expert Opin Investig Drugs. 2009 Dec;18(12):1885-91. doi: 10.1517/13543780903321508. Expert Opin Investig Drugs. 2009. PMID: 19888868 Review.
Inflammatory HER2-positive breast cancer.
Dirix LY, Vermeulen PB. Dirix LY, et al. Lancet Oncol. 2012 Apr;13(4):324-6. doi: 10.1016/S1470-2045(12)70081-5. Epub 2012 Feb 28. Lancet Oncol. 2012. PMID: 22377127 No abstract available.
International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment.
Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, Dirix LY, Levine PH, Lucci A, Krishnamurthy S, Robertson FM, Woodward WA, Yang WT, Ueno NT, Cristofanilli M. Dawood S, et al. Among authors: dirix ly. Ann Oncol. 2011 Mar;22(3):515-523. doi: 10.1093/annonc/mdq345. Epub 2010 Jul 5. Ann Oncol. 2011. PMID: 20603440 Free PMC article.
193 results